Answers are grounded in this paper and cite their sources.
BACKGROUND: Radiation-combined burn injury (RCB), defined as concurrent irradiation and burn injury, is expected to be common in radiological or nuclear mass-casualty events and can be highly lethal. The mechanisms underlying the irradiation-burn interaction remain poorly understood, particularly whether it amplifies capillary leak and inflammatory mediator responses to drive early lethality. We examined whether repeated low-dose monophosphoryl lipid A (MPLA) preconditioning modulates this response and whether KC/CXCL1 contributes to vascular leakage. METHODS: Male C57BL/6J mice underwent 6 Gy whole-body irradiation followed 1 h later by a 20% total body surface area full-thickness burn. MPLA (10 µg/mouse) or vehicle was administered intraperitoneally on days -4 and -3. We assessed 30-day survival, hemoconcentration, intravascular FITC-albumin retention, intestinal barrier endpoints, and cytokine/chemokine responses. A separate exploratory experiment evaluated pre-irradiation anti-KC/CXCL1 antibody treatment. RESULTS: Neither injury alone was lethal, whereas vehicle-treated RCB mice had 90% mortality (9 of 10 mice). Seven of these deaths occurred at 24-48 h after RCB. MPLA preconditioning increased 30-day survival from 10% to 80% (p = 0.0003) and eliminated deaths within 48 h. RCB induced hemoconcentration and tended to reduce FITC-albumin retention. Compared with vehicle-treated RCB mice, MPLA-preconditioned RCB mice had less hemoconcentration, significantly higher FITC-albumin retention, and lower mesenteric lymph node bacterial burden. MPLA preconditioning suppressed KC/CXCL1, which showed the largest absolute increase among measured cytokines/chemokines at 6 h. Anti-KC/CXCL1 antibody treatment significantly increased FITC-albumin retention at 6 h (p = 0.038). CONCLUSIONS: MPLA preconditioning improved survival after RCB. It may attenuate early inflammatory and vascular abnormalities. Exploratory antibody-treatment findings suggest a possible contribution of KC/CXCL1 to early vascular albumin leakage, warranting further validation.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: